CXCL13 has been proposed as a biomarker of neuroinflammatory disease due to its high level in the CNS under a variety of conditions, including multiple sclerosis and neuromyelitis optica [7] as well as CNS lymphoma [27, 28]. Here, CXCL13 is linked to neuromyelitis optica.